Ophthalmology · Little River, SC
NPI
1710050471
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
90 Cedar Light Ln
Little River, SC, 29566
Phone (843) 280-8779
Groups this clinician bills Medicare through
Medicare paid, 2024
$406K
5,993 services
Medicare patients, 2024
1,288
Average age 76
Drug cost, 2024
$582K
3,415 prescriptions
Company payments, 2025
$548
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jennifer H Merritt was code J0585 (injection, onabotulinumtoxina, 1 unit), 1,506 times for 15 patients. In total Jennifer H Merritt billed 5,993 services in 21 codes, and Medicare paid $406K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-11-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 1,506 | 15 | $4.81 | $7,237 |
| 92014 Ophthalmological E&M | Office | 548 | 548 | $78.55 | $43K |
| 92250 Angiography | Office | 521 | 510 | $22.75 | $12K |
| 99213 Office E&M - Established | Office | 515 | 406 | $59.63 | $31K |
| 92083 Vision, Hearing, and Speech Services | Office | 442 | 421 | $41.67 | $18K |
| 92136 Ultrasound - Nonspecific | Office | 432 | 263 | $27.58 | $12K |
| 92133 Computerized Ophthalmic Imaging | Office | 399 | 397 | $23.94 | $9,554 |
| 66984 Cataract Surgery | Facility | 384 | 223 | $393.81 | $151K |
| 99214 Office E&M - Established | Office | 369 | 359 | $84.86 | $31K |
| 99204 Office E&M - New | Office | 282 | 282 | $102.03 | $29K |
| 92134 Computerized Ophthalmic Imaging | Office | 218 | 202 | $26.77 | $5,835 |
| 66821 Cataract Surgery | Office | 175 | 119 | $246.50 | $43K |
| 76514 Ultrasound - Nonspecific | Office | 77 | 77 | $7.10 | $547 |
| 92004 Ophthalmological E&M | Office | 44 | 44 | $82.82 | $3,644 |
| 64612 Musculoskeletal | Office | 42 | 15 | $94.82 | $3,983 |
By year: 2022 $465K for 7,392 services; 2023 $416K for 6,164 services; 2024 $406K for 5,993 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jennifer H Merritt prescribed most often to Medicare patients was Prednisolone Acetate, with 647 prescriptions and refills. In total Jennifer H Merritt wrote 3,415 Medicare prescriptions that cost $582K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 647 | 656 | 364 | $20K |
| Latanoprost Generic | 617 | 1,181 | 161 | $5,546 |
| Erythromycin Erythromycin Base | 234 | 250 | 152 | $2,615 |
| Besivance Besifloxacin Hcl | 233 | 234 | 194 | $51K |
| Lumigan Bimatoprost | 227 | 430 | 54 | $114K |
| Timolol Maleate Generic | 207 | 469 | 62 | $4,093 |
| Brimonidine Tartrate Generic | 160 | 288 | 44 | $12K |
| Ilevro Nepafenac | 158 | 160 | 131 | $58K |
| Vyzulta Latanoprostene Bunod | 144 | 215 | 43 | $67K |
| Difluprednate Generic | 112 | 112 | 71 | $10K |
| Prolensa Bromfenac Sodium | 99 | 101 | 79 | $34K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 73 | 118 | 20 | $12K |
| Combigan Brimonidine Tartrate/Timolol | 51 | 83 | 13 | $16K |
| Restasis Cyclosporine | 38 | 90 | 21 | $54K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 38 | 85 | 14 | $924 |
Brand drugs: 1,998 claims; generic drugs: 1,417 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jennifer H Merritt $548 ($548 in general payments such as food, travel and fees) from 7 companies. The largest payer was Alcon Vision LLC with $182.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 10 | $182 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 6 | $171 |
| Abbvie Inc. ABBV | 5 | $114 |
| Harrow Eye, LLC | 1 | $23.02 |
| Oyster Point Pharma, Inc. | 1 | $20.59 |
| Bausch & Lomb Americas Inc. BLCO | 1 | $19.64 |
| RxSight Inc RXST | 1 | $18.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.